Ahmad Suhail, Al-Mutairi Noura M, Mokaddas Eiman
Department of Microbiology, Faculty of Medicine, Kuwait University, P.O. Box 24923, Safat, 13110, Kuwait.
Indian J Exp Biol. 2009 Jun;47(6):454-62.
Infections with multidrug-resistant (resistant at least to rifampicin, RIF and isoniazid, INH) strains of Mycobacterium tuberculosis (MDR-TB) are associated with high case fatality rates. Rapid identification' of MDR-TB strains is important for early institution of appropriate therapy. Two DNA line probe assays, GenoType MTBDR (GT-MTBDR) and INNO-LiPA Rif. TB (INNO-LiPA) were compared for their abilities to detect resistance to INH and RIF in 80 M. tuberculosis isolates. The test results were compared to those obtained by conventional drug susceptibility testing (DST), DNA sequencing and/or PCR-restriction fragment length polymorphism (RFLP) analysis of regions of interest of M. tuberculosis genome. Compared to the DST and katG codon 315 PCR-RFLP results, GT-MTBDR test results were concordant for INH resistance for 63 of 80 (78.7%) isolates. For RIF resistance, GT-MTBDR and INNO-LiPA test results were concordant with DST for 74 of 80 (92.5%) and 76 of 80 (95%) strains, respectively. The GT-MTBDR test results correlated with sequencing results for 77 of 80 (96.2%) while INNO-LiPA results for 79 of 80 (98.7%) isolates. Both the tests are useful for rapid detection of MDR-TB strains, however, GT-MTBDR assay offers the advantage of detecting the resistance to both INH and RIF simultaneously when MDR-TB is suspected.
耐多药(至少对利福平、RIF和异烟肼、INH耐药)结核分枝杆菌(MDR-TB)感染与高病死率相关。快速鉴定MDR-TB菌株对于尽早开始适当治疗很重要。比较了两种DNA线性探针检测方法,即GenoType MTBDR(GT-MTBDR)和INNO-LiPA Rif.TB(INNO-LiPA)检测80株结核分枝杆菌对INH和RIF耐药性的能力。将检测结果与通过传统药敏试验(DST)、DNA测序和/或结核分枝杆菌基因组感兴趣区域的PCR-限制性片段长度多态性(RFLP)分析获得的结果进行比较。与DST和katG密码子315 PCR-RFLP结果相比,GT-MTBDR检测结果在80株菌株中有63株(78.7%)对INH耐药性一致。对于RIF耐药性,GT-MTBDR和INNO-LiPA检测结果分别与80株菌株中的74株(92.5%)和76株(95%)的DST结果一致。GT-MTBDR检测结果与80株中的77株(96.2%)的测序结果相关,而INNO-LiPA结果与80株中的79株(98.7%)的菌株相关。这两种检测方法都有助于快速检测MDR-TB菌株,然而,当怀疑为MDR-TB时,GT-MTBDR检测方法具有同时检测对INH和RIF耐药性的优势。